Literature DB >> 14586723

Glomerulonephritis induced by methicillin-sensitive Staphylococcus aureus infection.

Tomohiro Handa1, Takahiko Ono, Hitomi Watanabe, Toshiya Takeda, Eri Muso, Toru Kita.   

Abstract

A 57-year-old woman developed exacerbation of atopic dermatitis, fever, and nephrotic syndrome with microscopic hematuria. By bacteriological study, methicillin-sensitive Staphylococcus aureus (MSSA) was detected from each culture of pharyngeal mucus, stool, and blood samples. Renal biopsy specimens showed endocapillary proliferative glomerulonephritis with massive IgA deposition in the mesangium and along the capillary loops. After antistaphylococcal therapy with antibiotics, MSSA was negative for each culture and urinary protein decreased. Nine months after the first renal biopsy, a re-biopsy was performed, which revealed apparent disappearance of both endocapillary cell proliferation and IgA deposition. It is known that methicillin-resistant S. aureus (MRSA) infection causes glomerulonephritis through T-cell stimulation by superantigen presented by MRSA. The present results suggest that not only MRSA but also MSSA can cause this type of glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586723     DOI: 10.1007/s10157-003-0240-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  12 in total

1.  Henoch-Schönlein purpura due to methicillin-sensitive Staphylococcus aureus bacteremia from central venous catheterization.

Authors:  Simona Uggeri; Fabio Fabbian; Luigi Catizone
Journal:  Clin Exp Nephrol       Date:  2008-01-09       Impact factor: 2.801

2.  IgA-dominant postinfectious glomerulonephritis induced by methicillin-sensitive Staphylococcus aureus.

Authors:  Joana Caetano; Fernando Pereira; Susana Oliveira; José Delgado Alves
Journal:  BMJ Case Rep       Date:  2015-05-14

3.  The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study.

Authors:  Takaya Handa; Hiroko Kakita; Yu Tateishi; Tomomi Endo; Hiroyuki Suzuki; Toshiro Katayama; Tatsuo Tsukamoto; Eri Muso
Journal:  Clin Exp Nephrol       Date:  2018-03-21       Impact factor: 2.801

Review 4.  Staphylococcus aureus Infection-Related Glomerulonephritis with Dominant IgA Deposition.

Authors:  Mamiko Takayasu; Kouichi Hirayama; Homare Shimohata; Masaki Kobayashi; Akio Koyama
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

5.  IgA-dominant Staphylococcus infection-associated glomerulonephritis: case reports and review of the literature.

Authors:  Edgard Wehbe; Charbel Salem; James F Simon; Sankar D Navaneethan; Marc Pohl
Journal:  NDT Plus       Date:  2011-03-08

6.  IgA dominant postinfectious glomerulonephritis: Report of two cases.

Authors:  V Rajakumar; S A K Noor Mohamed; A A Kurien; M E Fernando
Journal:  Indian J Nephrol       Date:  2014-05

7.  Clinical, Pathological, and Prognostic Characteristics of Glomerulonephritis Related to Staphylococcal Infection.

Authors:  Si-Yang Wang; Ru Bu; Qi Zhang; Shuang Liang; Jie Wu; Xue-Guang Zhang Shu-Wen Liu; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

8.  Clinicopathologic Features of IgA-Dominant Postinfectious Glomerulonephritis.

Authors:  Tai Yeon Koo; Gheun-Ho Kim; Moon Hyang Park
Journal:  Korean J Pathol       Date:  2012-04-25

9.  Glomerulonephritis causing acute renal failure during the course of bacterial infections. Histological varieties, potential pathogenetic pathways and treatment.

Authors:  Jorge I Zeledon; Robin L McKelvey; Karen S Servilla; Diedre Hofinger; Konstantin N Konstantinov; Suzan Kellie; Yijuan Sun; Larry W Massie; Michael F Hartshorne; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.266

10.  Devastating renal outcome caused by skin infection with methicillin-resistant Staphylococcus aureus: A case report.

Authors:  Jun-Hua Liang; Yu-Wei Fang; An-Hung Yang; Ming Hsien Tsai
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.